Elite Pharma Private Limited - Company Profile

Q: Where is Elite Pharma Private Limited headquartered?

Elite Pharma Private Limited is headquartered at 12101112, Phase Iii, G.I.D.C. Estate, Vatva, Ahmedabad, Gujarat, 382445.

Q: Who are the current directors of Elite Pharma Private Limited?

The current directors of Elite Pharma Private Limited are Girish Khimji Kantaria, Jatin Popatlal Patel, Chintan Hareshbhai Patel.

It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 1987.

1987 Ahmedabad, Gujarat, India Active

Last Updated: January 09, 2026

Access Report

About Elite Pharma Private Limited

Elite Pharma Private Limited, a active private limited company, was established on 16 October 1987 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1987PTC010062. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.20 M and a paid-up capital of ₹1.10 M.

It upholds a compliant status. Employing 7 professional, Its leadership includes Girish Khimji Kantaria (Director), Jatin Popatlal Patel (Director), Chintan Hareshbhai Patel (Director). Past directors included Haresh Laxmanbhai Patel, Popatlal Harjibhai Patel. It holds no open charges and ₹1.25 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1210/11/12, Phase Iii, G.I.D.C. Estate, Vatva, Ahmedabad, Gujarat, 382445.

Company Details

CIN/LLPIN
U24231GJ1987PTC010062
Registration Number
010062
Incorporation Date
16 October 1987
Authorized Capital
₹1.20 M
Paid-Up Capital
₹1.10 M
ROC Code
Roc Ahmedabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.20 M as on 09-01-2026
Paid Up Capital ₹ 1.10 M as on 09-01-2026
Company Age 38 Year, 3 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 1.25 Cr as on 09-01-2026
Revenue Growth **** 0.93% (FY 2024)
Profit Growth **** 20.21% (FY 2024)
Ebitda **** -12.98% (FY 2024)
Net Worth 10.66% (FY 2024)
Total Assets **** 9.91% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Elite Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Elite Pharma Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Girish Khimji Kantaria	Director	16 Oct 1987	Current
Jatin Popatlal Patel	Director	04 May 2025	Current
Chintan Hareshbhai Patel	Director	28 Apr 2017	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	01 Mar 2017	Past
Pramod Abcsdd	Director	14 May 2025	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elite Pharma.

Elite Pharma Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.93% increase. The company also saw a substantial improvement in profitability, with a 20.21% increase in profit. The company's net worth Soared by an impressive increase of 10.66%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

0.93%

*******

Revenue from Operations

*******

-1.49%

*******

Total Assets

*******

9.91%

*******

Profit or Loss

*******

20.21%

*******

Net Worth

*******

10.66%

*******

EBITDA

*******

-12.98%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elite Pharma?

Unlock access to Elite Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹12,487,000.00

Charges Breakdown by Lending Institutions

Bank Of India : 1.25 Cr

Latest Charge Details

Date	Lender	Amount	Status
17 Jun 2005	Bank Of India	₹3.70 M	Satisfied
27 Dec 2003	Bank Of India	₹6.19 M	Satisfied
05 Feb 1996	Bank Of India	₹0.20 M	Satisfied
08 Apr 1989	Bank Of India	₹2.40 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Elite Pharma?

Elite Pharma has a workforce of 7 employees as of Mar 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Elite Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elite Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elite Pharma

Recent Activity within the Organization

Annual General Meeting

Elite Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Director Appointment

Progress on Jatin Popatlal Patel was appointed as a Director was appointed as a Director on 04 May 2025 & has been associated with this company since 9 months 10 days . was documented.
04 May 2025
Balance Sheet

The activity Elite Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
31 Mar 2025
Charges

Progress on A charge registered on 17 Jun 2005 via Charge ID 90112999 with Bank Of India was fully satisfied on 08 Mar 2018. was documented.
08 Mar 2018
Charges

A charge registered on 27 Dec 2003 via Charge ID 90112846 with Bank Of India was fully satisfied on 08 Mar 2018. was recorded as a recent event.
08 Mar 2018
Charges

Progress on A charge registered on 05 Feb 1996 via Charge ID 90109382 with Bank Of India was fully satisfied on 08 Mar 2018. was documented.
08 Mar 2018

Explore recent activity and updates - View Recent Activity